Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine

Clicks: 328
ID: 267475
2013
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #38 of 86 articles by views in Vaccine

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Group B Streptococcus (GBS) emerged as the leading cause of newborn infection in the United States in the 1970s. In the 1980s clinical trials demonstrated that giving intrapartum intravenous ampicillin or penicillin to mothers at risk was highly effective at preventing invasive GBS disease in the fi …
Reference Key
sj2013vaccineintrapartum Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Schrag SJ;Verani JR;;
Journal Vaccine
Year 2013
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/23219695
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE review humans pubmed abstract nih national institutes of health national library of medicine pregnancy research support u.s. gov't female Infant newborn P.H.S. United States anti-bacterial agents / therapeutic use penicillins / therapeutic use streptococcal infections / microbiology premature birth infectious disease transmission streptococcal infections / drug therapy* antibiotic prophylaxis / methods* jennifer r verani diseases / prevention & control vertical / prevention & control* pmid:23219695 doi:10.1016/j.vaccine.2012.11.056 stephanie j schrag ampicillin / therapeutic use diseases / drug therapy* diseases / microbiology prenatal diagnosis reproductive tract infections / drug therapy* reproductive tract infections / microbiology streptococcal infections / prevention & control streptococcal vaccines streptococcus agalactiae / immunology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.